Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome
Jian Tian
Diabetic Medicine
· Wiley
· 2026-11-16
· DOI: 10.1111/dme.70533
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Jian Tian. Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome. // Diabetic Medicine. – 2026. – DOI: 10.1111/dme.70533. – URL: https://onlinelibrary.wiley.com/doi/10.1111/dme.70533?af=R
Jian Tian (2026). Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome. Diabetic Medicine. https://doi.org/10.1111/dme.70533
Jian Tian. “Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome.” Diabetic Medicine, 2026. doi:10.1111/dme.70533.
@article{Tian2026,
title = {Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome},
author = {Tian, Jian},
journal = {Diabetic Medicine},
year = {2026},
doi = {10.1111/dme.70533},
url = {https://onlinelibrary.wiley.com/doi/10.1111/dme.70533?af=R}
}